Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 10, Art. 12 (pp. 168-187)    |    2009       

»

Prognostic significance of quality of life assessment in patients with malignant lymhomas

Novitskiy A.V., Sukhonos Y.A., Petlenko C.V.

Medical-Military academy, St-Petersburg

Brief summary

Prognostic significance of quality of life assessments was studied in patients with malignant lymphomas before, during and at the end of chemotherapy treatment. Russian version of questioner 168 WWW.MEDLINE.RU ТОМ10, ОНКОЛОГИЯ, ОКТЯБРЬ 2009 QLQ-30 and was used during all period of treatment. The study included 177 patients. Different factors such as sex, age, disease stage and morphology, performance status were investigated in their influence on quality of life in lymphomas patients.


Key words

quality of life, malignant lymphomas, prognostic factors

Reference list

1. Aaronson N.K. Methodologic issues in assessing the quality of life of cancer patients // Cancer. – 1991. – Vol.67. - №3. – P.844-950.


2. Aaronson N.K., Cull A., Kaasa S., Sprangers M. The European Organisation for Research and Treatment of Cancer (EORTC) Modular Approach to Quality of Life Assessment in Oncology // Int.J.Ment.Health. - 1994. N 23.-P.75-96.


3. Anderson T., DeVita V.T. Jr., Simon R.M., Berard C.W., Canellos G.P., Garvin A.J., Young R.C. Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients of the National Cancer Institute // Cancer. – 1982. – Vol.50. - №12. – P.2708-2721.


4. Borstlap M., Zant J.L., Van Soesbergen R.M., Van der Korst J.K. Quality of life assesment: A comparison of four questionnares: for meassuring improvement after total hip replacement. // Clin. Reumatol. - 1995. - Vol.14, N.1. - P. 15-21.


5. Cancer Patient Survival Report #5, United States Department of Health Education and Welfare, Publ. No. (NIH) 77-992, 1976.


6. Cella D.F., Cherin E.A. Quality of life during and after cancer treatment // Compr. Ter. – 1988. – Vol.14. - №5. – P.69-75.


7. Coast J., Peters T.J., Richards S.H. and Gunnell D.J.. Use of the EuroQOL among elderly acute care patients. // Quality of Life Research - N.7, - 1998; N1:1-10.


8. Cull A., Hag C., Love S.B., Mackie M., Smets E., Stewart M. What do cancer patients mean when they complain of concentration and memory problems? // Br. J. Cancer. – 1996. – Vol.74. - №10. – P.1674-1679.


9. Detmar S.B., Aaronson N.K. Quality of life assessment in daily clinical oncology practice: a feasibility study // Eur. J. Cancer. – 1998. – Vol.34. - №8. – P.1181-1186.


10. Devlen J., Maguire P., Phillips P., Crowther D., Chambers H. Psychological problems associated with diagnosis and treatment of lymphomas. I: Retrospective study // Br. Med. J. - 1987. – Vol.295. – P.953-954.


11. Donovan K., Sanson-Fisher R.W., Redman S. Measuring quality of life in cancer patients // J. Clin Oncol. – 1989. – Vol.7. - №7. – P.959-968.


12. Dumontet C., Bastion Y., Felman P., Ffrench M., Blanc M., Peaud P.Y., Bryon P.A., Coiffier B. Prognostic factors, late relapse and outcome of patients with aggressive malignant lymphoma: long term results of LNH-80 protocol // Bull. Cancer. –1992. – Vol.79. – №10. – P.979-989.


13. Fayers P., Aaronson N., Bjordal K., Sullivan M. EORTC QLQ-C30 scoring manual. EORTC Study Group on Quality of Life, Brussels, - 1995 - P. 50.


14. Fitzpatrick R., Fletcher A., Gore S., Jones D., Spiegelhalter D., Cox D. Quality of life measures in health care. I. Applications and issues in assessment // Br. Med. J. – 1992. – Vol.305. - №6861. – P.1074-1077.


15. Fleishman S.B., Kosty M., Herndon J., Kornblith A.B., Duggan D., Morris J., Mortimer J., Holland J.C., Green M.R. Quality of life (QoL) predicts survival in advanced nonsmall cell lung cancer. A cancer and leukemia Group B (CALGB) Study 8931. - Proc Annu Meet Am Soc Clin Oncol (1994).


16. Forth Annual Conference of the International Society for Quality of Life Research:Abstracts // Quality of Life Research.-1997.-N7/8.-P.613-747.


17. Frei E. 3rd. Randomized clinical trials and other approaches in clinical research // Cancer. - 1994. – Vol.74. – №.9 suppl. – P.2610-2613.


18. Ganz P.A. Long-range effect of clinical trial interventions on quality of life // Cancer. – 1994. – Vol.74. - №9 (suppl.). – P.2620-2624.


19. Giesler R.B., Williams S.D. Opportunities and challenges: Assessing quality of life in clinical trials // J. Natl. Cancer Inst. – 1998. – Vol.90. - №20. – P.1498-1499.


20. Greil R. Prognosis and management strategies of lymphatic neoplasias in the elderly. II. Hodgkin’s disease // Oncology. – 1998. – Vol.55. - №4. – P.265-275.


21. Hadorn D.C., Uebersax J. Large-scale health outcames evaluation: How should quality of life be measured? // J. Clin. Epidemiol. - 1995. - Vol.48, N.5. - P.607-631.


22. Hellman S. Principies of radiation therapy. In DeVita VT, Jr., Hellman S, Rosenberg SA, eds. Cancer: Principies and practice of oncology. Philadelphia: Lippincott, 1985; 227-255.


23. Hicks J.E., Lampert M.H., Gerber L.H., Glatstein E., Danoff J. Functional outcome update in patients with soft tissue sarcoma undergoing wide local excision and radiation. // Arch Phys Med Rehabil. - 1985. - N.66. - P.542-543.


24. Hjermstad M.J., Fossa S.D., Bjordal K., Kaasa S. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. // J Clin Oncol. - 1995. - May, N.13(5). - P.1249-1254.


25. Joly F., Henry-Amar M., Arveux P., Reman O., Tanguy A., Peny A.-M., Lebailly P., Mace-Lesec’h J., Vie B., Genot J.-Y., Busson A., Troussard X., Leporrier M. Late psychosocial sequelae in Hodgkin’s disease survivors: a French population-based case-control study // J. Clin. Oncol. – 1996. – Vol.14. - №9. – P.2444-2453.


26. Julious S.A., George S., Campbell M.J. Sample sizes for studies using the short form 36 (SF-36). // J.Epid.&Community Health. -1995. - Vol.49, N.6. - P. 642-645.


27. Kaasa S. Using quality of life assessment methods in patients with advanced cancer: a clinical perspective. // Eur J Cancer. - 1995. - N. 31A. - Suppl. 6. - P.15-17


28. Kaasa S., Bjordal K., Aaronson N., Moum T., Wist E., Hagen S., Kvikstad A. The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. // Eur J Cancer. - 1995. Dec. - Vol. 31A, N.13-14. - P.2260-3.


29. Kaasa S., Knobel H., Loge J.H., Hjermstad M.J. Hodgkin's disease: quality of life in future trials // Ann. Oncol. – 1998. – Vol.9. – №5 (suppl.). – P.137-145.


30. King M.T., Dobson A.J., Harnett P.R. A comprasion of two quality of life questionnares for cancer clinical trials: FLIC & QLQ-C30. // J. Clin. Epidemiol. - 1996. - Vol.49, N.1. - P.21-31.


31. Kornblith A.B., Anderson J., Cella D.F., Tross S., Zuckermann E., Cherin E., Henderson E., Weiss R.B., Cooper M.R., Silver R.T., Leone l., Canellos G.P., Gottlieb A., Holland J.C. Hodgkin’s disease survivors at increased risk for problems in psychological adaptation // Cancer. – 1992. – Vol.70. – №8. – P.2214-2224.


32. Llewellyn-Thomas H.A., Sutherland H.J., Tibshirani R., Ciampi A., Till J.E., Boyd N.F. Describing health states: Methodological issues in obtaning values for health states. - Med Care.- 1984. - N.22. - P.543-552.


33. Mandelblatt J.S., Eisenberg J.M. Historical and methodological perspectives on cancer outcomes research // Oncology. – 1995. – Vol.9. - №11 (suppl.). – P.23-32.


34. Michael M., Tannock I.F. Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment // Can. Med. Assoc. J. – 1998. – Vol.158. - №13. – P.1727-1734.


35. National Institutes of Health Consensus Conference, Limb-sparing treatment of adult soft-tissue sarcomas and osteosarcomas. // JAMA. - 1985. - N. 254. - P.1791-1794.


36. Neymark N., Kiebert W., Torfs K., Davies L., Fayers P., Hillner B., Gelber R., Guyatt G., Kind P., Machin D., Nord E., Osoba D., Revicki D., Schulman K., Simpson K. Methodological and statistical issues of quality of life and economic evaluation in cancer clinical trials: report of a workshop // Eur. J. Cancer. – 1998. – Vol.34. - №9. – P.1317-1333.


37. Norum J., Wist EA. Hodgkin disease treated at the Troms‡ regional hospital 1985-93. Diagnosis, treatment, prognosis, quality of life and costs of a decentralized treatment // Tidsskr.Nor. Laegeforen. - 1997. – Vol.117. – №1. – P.23-26.


38. Pater J.L., Darko E., Zee B. Impact of nausea and vomiting (PNV) on quality of life (QL) of patients (pts) receiving cytotoxic chemotherapy. // Ann Oncol. - 1992. - N.3. - Suppl 5. - P.177.


39. Rosenberg S.A. Soft tissue sarcoma of the extremities. In: Surarbaker PH, Nicholson TH, eds. Atlas of extremity sarcoma surgery, Philadelphia: Lippincott, 1984: 1-17.


40. Sanger C.K., Reznikoff M. A comprasion of the psychological effects of breast-saving procedures with the modified radical mastectomy. // Cancer. - 1981. - N. 48. - P.2341-2346.


41. Schumacher A., Kessler Th., Krallmann C., van de Loo J. Quality of life in patients with acute myeloid leukemia - - a longitudinal study (Meeting abstract). // Proc Annu Meet Am Soc Clin Oncol - 1994.


42. Simons J.P., Aaronson N.K., Vansteenkiste J.F., ten Velde G.P., Muller M.J., Drenth B.M., Erdkamp F.L., Cobben E.G., Schoon E.J., Smeets J.B., Schouten H.C., Demedts M., Hillen H.F., Blijham G.H., Wouters E.F. Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study. // J Clin Oncol. - 1996. - Apr. - Vol. 14,N.4. - P.1077-84.


43. Skeel R.T. Quality of life assessment in cancer clinical trials – it’s time to catch up // J. Natl. Cancer Inst. – 1989. – Vol.81. - №7. – P.472-473.


44. Sugarbaker P.H., Barofsky I., Rosenberg S.A., Gianola F.J. Quality of life assessment of patients in extremity sarcoma clinical trials.// Surgery. - 1982. - Vol.91. - P.17-23.


45. Sutherland H.J., Llewellyn-Thomas H.A., Boyd N.F., Till J.E. Attitudes towards quality of survival: The concept of "maximal endurable time". // Med Decis Making. - 1982. - Vol.2. - P. 229-309.


46. Therasse P. A practical guide to EORTC (European Organization for Research and Treatment of Cancer) studies. EORTC Data Center, Brussels, - 1996.


47. Tennant A., Hillman M., Fear J., Pickering A. & Chamberlain M.A. Are we making most of the Stanford Health Assessment Questionaire // Br. J.Rheumatol. - 1996. - Vol.35, N.6. - P.574-578.


48. Torrance G.W. Health states worse than death. In: van Eimeren W, Engelbrecht R, Flagle CD, eds. Third International Conference on System Science in Health Care. Berlin: Springer, 1984: 1085-1089.


49. van Tulder M.W., Aaronson N.K., Bruning P.F. The quality of life of long-term survivors of Hodgkin's disease // Ann. Oncol. – 1994. – Vol.5. – №2. – P.153-158.


50. Williams N.S., Johnston D. The Quality of life after rectal excision for low rectal cancer. // Br J Surg. - 1983. - Vol.70. - P.219-225.


51. Wolf A.M., Hunter D..J., Colditz GA., Manson J.E., Stampfer N.J., Corsano K.A., Rosner B., Kriska A., Wollet W.C. Reproducibility & validity of self-administrated physical activity questionnaire // Int. J. Epidemiol. - 1994. - Vol.23, N.5. - P.991-999.


52. Wolfe F. Health status questionnaires // Rheum. Dis. Clin. North Amer. - 1995. - Vol.21, N.2. - P.445-464.